Changes After Suprachoroidal Injection. (NCT05288192) | Clinical Trial Compass
UnknownNot Applicable
Changes After Suprachoroidal Injection.
Egypt30 participantsStarted 2022-02-15
Plain-language summary
Changes after suprachoroidal injection are analyzed for statistical analysis.
Who can participate
Age range30 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study.
* Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies.
Exclusion Criteria:
* Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations.
* Choroidal neovascularization that require anti-vascular endothelial growth factors.
* Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.
What they're measuring
1
Changes in visual acuity
Timeframe: Monthly after injection till six months of follow up
2
Changes in central foveal thickness
Timeframe: Monthly after injection till six months of follow up